Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Skin Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Melanoma 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Recurrence 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1 Mouth Neoplasms 1 Malignant Ascites 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Small Cell 1 Carcinoma, Endometrioid 1 Carcinoma 1

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Carcinoma, Small Cell × pembrolizumab × Clear all

NCT05368207 2024-03-13

Pemb-HT

University Health Network, Toronto

Phase NA Unknown

Ovarian Neoplasms, Carcinoma, Small Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡